Harnessing the interaction between redox signaling and senescence to restrain tumor drug resistance

Abstract excerpt

The persistent challenge of tumor drug resistance remains a critical issue in medical practice, particularly during anti-neoplastic therapies, where the plasticity of the tumor microenvironment (TME) significantly complicates clinical treatment. Cellular senescence, an irreversible and permanent arrest of the cell cycle, has been implicated in various vital physiological and pathological processes. However,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Immune cells in cancer
• Share to Nanoplatforms for cancer theranostics
• Share to Telomeres, Telomerase, and Senescence